Activation of NF-κB transcription factors by TNFα promotes the upregulation of c-FLIP and enhances skin tumor cell survival, and confers their resistance to RAF inhibitor treatment [48, 67]. The gene discussed is NFKB1; the disease is skin neoplasm.